Verrica Pharmaceuticals Files 2024 10-K
Ticker: VRCA · Form: 10-K · Filed: Mar 11, 2025 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | 10-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Verrica Pharma dropped its 2024 10-K. Check financials for FY24.
AI Summary
Verrica Pharmaceuticals Inc. filed its 2024 10-K on March 11, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware and headquartered in West Chester, PA, operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal year 2024 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with Verrica Pharmaceuticals' comprehensive financial performance and operational overview for the 2024 fiscal year, crucial for assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Verrica is subject to inherent risks related to drug development, regulatory approvals, market competition, and financial performance, which are detailed in its 10-K filing.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-11 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Filer of the 10-K
- 0000950170-25-037172 (other) — Accession Number for the filing
- 2024-12-31 (date) — Fiscal year end
- 2025-03-11 (date) — Filing date
- West Chester, PA (location) — Company headquarters
- 484-453-3300 (phone_number) — Business phone number
FAQ
What is the primary business of Verrica Pharmaceuticals Inc. as indicated in the filing?
Verrica Pharmaceuticals Inc. is primarily involved in the pharmaceutical preparations sector, as indicated by its Standard Industrial Classification code [2834].
When did Verrica Pharmaceuticals Inc.'s fiscal year end for this report?
The conformed period of report for Verrica Pharmaceuticals Inc. is 2024-12-31, meaning its fiscal year ended on December 31, 2024.
What is the SEC file number for Verrica Pharmaceuticals Inc.'s 10-K filing?
The SEC file number for Verrica Pharmaceuticals Inc.'s 10-K filing is 001-38529.
Where is Verrica Pharmaceuticals Inc. headquartered?
Verrica Pharmaceuticals Inc. is headquartered at 10 North High Street, Suite 200, West Chester, PA 19380.
On what date was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on 2025-03-11.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 11, 2025 regarding Verrica Pharmaceuticals Inc. (VRCA).